Received Aug 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
an adult was given a pediatric dose of Engerix B; an adult was given a pediatric dose of Engerix B; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of adult use of a child product in a adult patient who received HBV (Engerix B pediatric) for prophylaxis. On 16-JUL-2025, the patient received Engerix B pediatric. On 16-JUL-2025, an unknown time after receiving Engerix B pediatric, the patient experienced adult use of a child product (Verbatim: an adult was given a pediatric dose of Engerix B) and underdose (Verbatim: an adult was given a pediatric dose of Engerix B). The outcome of the adult use of a child product and underdose were not applicable. Additional Information: GSK Receipt Date: 17-JUL-2025 Pharmacist reported that an adult was given a pediatric dose of Engerix B, which led to adult use of a child product and underdose. The reporter was consented to follow up. No further details were available regarding patient or product.